DMII
Drugs Made In America Acquisition Ii
$10.17
+$0.01 (+0.1%)Sep 10, 2026
Key metrics
The numbers that frame DMII today
- Market cap
- $647.83M
- P/E (TTM)
- 49.8
- EV / FCF
- -506.0
- ROIC
- 2.6%
- Div yield
- 0%
Growth
Revenue and earnings trend for DMII
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DMII
Is Drugs Made In America Acquisition Ii a good buy?
No. Drugs Made In America Acquisition Ii has poor quality. We think Drugs Made In America Acquisition Ii is selling at a fair price.
What is the market capitalization of DMII?
Drugs Made In America Acquisition Ii's market capitalization is $647.83M.
What is the P/E ratio for DMII stock?
Drugs Made In America Acquisition Ii's current P/E ratio is 49.8.
Does DMII stock pay dividends?
Drugs Made In America Acquisition Ii does not currently show a dividend per share in the company data.